...
首页> 外文期刊>Bone marrow transplantation >Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation
【24h】

Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation

机译:同种异体干细胞移植前维生素D缺乏症患者慢性GVHD和CMV病的发病率增加

获取原文
获取原文并翻译 | 示例
           

摘要

Vitamin D has emerged as a central player in the immune system, with its deficiency being implicated in the pathogenesis of several autoimmune diseases, including chronic GvHD. This is a retrospective cohort analysis of 166 patients, who underwent allogeneic hematopoietic stem cell transplantation (HSCT) at the Karolinska University Hospital, evaluating GvHD, graft failure, infectious complications and survival after HSCT in relation to pre-transplantation vitamin D levels. Most of the patients were deficient in vitamin D before HSCT (median 42 nmol/L). In multivariate analysis, vitamin D level before HSCT was identified as a significant independent risk factor for development of cGvHD. The increased incidence of cGvHD was not coupled to better disease-free survival; instead there was a trend towards lower overall survival in the vitamin D-deficient patients. In addition, we found a significant correlation between vitamin D deficiency and incidence of CMV disease, with no case of CMV disease occurring in patients with sufficient levels of vitamin D before HSCT. Our results support a role of vitamin D in immune tolerance following HSCT. These findings could be highly relevant for the care of HSCT patients, and prospective, randomized studies on the effect of vitamin D supplementation are therefore needed.
机译:维生素D已成为免疫系统中的中央球员,其缺乏涉及几种自身免疫疾病的发病机制,包括慢性GVHD。这是166名患者的回顾性队列分析,在Karolinska大学医院进行同种异体造血干细胞移植(HSCT),评估GVHD,移植衰竭,传染性并发​​症和在HSCT相关的预移植前维生素D水平。大多数患者在HSCT之前缺乏维生素D(中位数42 Nmol / L)。在多变量分析中,HSCT之前的维生素D水平被确定为CGVHD发育的重要危险因素。 CGVHD的发病率增加未加入更好的无疾病存活;相反,维生素D缺陷患者的整体生存率较低。此外,我们发现维生素D缺乏和CMV疾病发病率之间的显着相关性,没有CMV疾病的患者,在HSCT之前的维生素D水平充足。我们的研究结果支持在HSCT后维生素D在免疫耐受性中的作用。因此,这些发现可能对HSCT患者的护理非常相关,因此需要对维生素D补充的效果的前瞻性随机研究。

著录项

  • 来源
    《Bone marrow transplantation》 |2015年第9期|共7页
  • 作者单位

    Karolinska Univ Hosp Dept Med Hematol Ctr Stockholm Sweden;

    Karolinska Inst Dept Med Div Infect Dis S-14186 Stockholm Sweden;

    Karolinska Inst Dept Lab Med Div Clin Immunol &

    Transfus Med Ctr Hematol &

    Regenerat Med S;

    Karolinska Univ Hosp Dept Med Hematol Ctr Stockholm Sweden;

    Karolinska Univ Hosp Dept Med Hematol Ctr Stockholm Sweden;

    Univ Erlangen Nurnberg Dept Internal Med Hematol &

    Oncol 5 D-91054 Erlangen Germany;

    Karolinska Univ Hosp Dept Med Hematol Ctr Stockholm Sweden;

    Univ Regensburg Inst Funct Genom D-93053 Regensburg Germany;

    Hop St Antoine Serv Hematol &

    Therapie Cellulaire F-75571 Paris France;

    Karolinska Univ Hosp Dept Med Hematol Ctr Stockholm Sweden;

    Karolinska Univ Hosp Dept Med Hematol Ctr Stockholm Sweden;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 治疗学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号